RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Harmony Biosciences Holdings - Stock

Harmony Biosciences Holdings EBIT 2024

Harmony Biosciences Holdings EBIT

195.4 M USD

Ticker

HRMY

ISIN

US4131971040

WKN

A2QBSF

In 2024, Harmony Biosciences Holdings's EBIT was 195.4 M USD, a 1.75% increase from the 192.03 M USD EBIT recorded in the previous year.

The Harmony Biosciences Holdings EBIT history

YEAREBIT (undefined USD)
2029e-
2028e1.04
2027e0.58
2026e0.4
2025e0.3
2024e0.2
20230.19
20220.12
20210.09
20200.02
2019-0.15
2018-0.04

Harmony Biosciences Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Harmony Biosciences Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Harmony Biosciences Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Harmony Biosciences Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Harmony Biosciences Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Harmony Biosciences Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Harmony Biosciences Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Harmony Biosciences Holdings’s growth potential.

Harmony Biosciences Holdings Revenue, Profit, and EBIT History

DateHarmony Biosciences Holdings RevenueHarmony Biosciences Holdings EBITHarmony Biosciences Holdings Net Income
2029e1.53 B undefined0 undefined195.21 M undefined
2028e1.83 B undefined1.04 B undefined321.49 M undefined
2027e1.24 B undefined583.61 M undefined575.2 M undefined
2026e1.01 B undefined399.64 M undefined296.46 M undefined
2025e856.08 M undefined303.32 M undefined225.72 M undefined
2024e724.01 M undefined195.4 M undefined128.93 M undefined
2023582.02 M undefined192.03 M undefined128.85 M undefined
2022437.9 M undefined120.2 M undefined181.5 M undefined
2021305.4 M undefined87.5 M undefined34.6 M undefined
2020159.7 M undefined16.9 M undefined-63.8 M undefined
20196 M undefined-145.9 M undefined-187.2 M undefined
20180 undefined-41.4 M undefined-70.1 M undefined

Harmony Biosciences Holdings stock margins

The Harmony Biosciences Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Harmony Biosciences Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Harmony Biosciences Holdings.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Harmony Biosciences Holdings's sales revenue. A higher gross margin percentage indicates that the Harmony Biosciences Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Harmony Biosciences Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Harmony Biosciences Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Harmony Biosciences Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Harmony Biosciences Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Harmony Biosciences Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Harmony Biosciences Holdings Margin History

Harmony Biosciences Holdings Gross marginHarmony Biosciences Holdings Profit marginHarmony Biosciences Holdings EBIT marginHarmony Biosciences Holdings Profit margin
2029e79.17 %0 %12.79 %
2028e79.17 %56.61 %17.57 %
2027e79.17 %47.07 %46.39 %
2026e79.17 %39.57 %29.35 %
2025e79.17 %35.43 %26.37 %
2024e79.17 %26.99 %17.81 %
202379.17 %32.99 %22.14 %
202280.93 %27.45 %41.45 %
202181.83 %28.65 %11.33 %
202082.65 %10.58 %-39.95 %
201973.33 %-2,431.67 %-3,120 %
201879.17 %0 %0 %

Harmony Biosciences Holdings Aktienanalyse

What does Harmony Biosciences Holdings do?

Harmony Biosciences Holdings Inc is a US-based company specialized in the development and marketing of innovative therapies and treatments for neurological disorders. The company was founded in 2017 and is headquartered in Plymouth Meeting, Pennsylvania. Harmony Biosciences' business model is based on the development of drugs specifically designed to treat sleep disorders and other neurological diseases. The company is a leader in research and development of new compounds in this field and collaborates closely with leading research institutes and experts in the field of sleep medicine. Harmony Biosciences' products are divided into various categories, including narcolepsy, sleep apnea, and other sleep-related disorders. Some of the most well-known products include Pitolisant and Wakix, which are used to treat narcolepsy and EDS. Pitolisant has been approved by the European Medicines Agency and is the first and only drug approved for the treatment of type 1 narcolepsy. Harmony Biosciences heavily invests in research and development of new technologies and approaches to treat sleep disorders and other neurological diseases. The company maintains a strong network of partnerships and collaborations with leading institutes and experts in the field. The goal is to develop new drugs and therapies that improve the quality of life for patients with sleep disorders and other neurological diseases. In addition to drug development, Harmony Biosciences' employees are actively involved in educating and raising awareness about sleep disorders and their impact on health. The company informs and advises patients and their families about various treatment options and actively works on developing new technologies and approaches to improve the diagnosis and treatment of neurological diseases. Overall, Harmony Biosciences aims to improve the quality of life for millions of patients with sleep disorders and other neurological diseases. The company focuses on strategic and collaborative research and development of new technologies and approaches for treating these conditions. With its team of experts and scientists, Harmony Biosciences upholds high standards in research and follows the strict criteria of the medical device industry to develop innovative therapies and medications that will improve the lives of patients worldwide. Harmony Biosciences Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Harmony Biosciences Holdings's EBIT

Harmony Biosciences Holdings's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Harmony Biosciences Holdings's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Harmony Biosciences Holdings's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Harmony Biosciences Holdings’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Harmony Biosciences Holdings Stock

How much did Harmony Biosciences Holdings achieve in EBIT for the current year?

In the current year, Harmony Biosciences Holdings has achieved an EBIT of 195.4 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Harmony Biosciences Holdings.

How has the EBIT of Harmony Biosciences Holdings developed in recent years?

The EBIT of Harmony Biosciences Holdings has increased by 1.755% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Harmony Biosciences Holdings?

The EBIT of Harmony Biosciences Holdings is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Harmony Biosciences Holdings pay?

Over the past 12 months, Harmony Biosciences Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Harmony Biosciences Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Harmony Biosciences Holdings?

The current dividend yield of Harmony Biosciences Holdings is .

When does Harmony Biosciences Holdings pay dividends?

Harmony Biosciences Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Harmony Biosciences Holdings?

Harmony Biosciences Holdings paid dividends every year for the past 0 years.

What is the dividend of Harmony Biosciences Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Harmony Biosciences Holdings located?

Harmony Biosciences Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Harmony Biosciences Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Harmony Biosciences Holdings from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Harmony Biosciences Holdings pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Harmony Biosciences Holdings in the year 2023?

In the year 2023, Harmony Biosciences Holdings distributed 0 USD as dividends.

In which currency does Harmony Biosciences Holdings pay out the dividend?

The dividends of Harmony Biosciences Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Harmony Biosciences Holdings

Our stock analysis for Harmony Biosciences Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Harmony Biosciences Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.